DHFR and cancer: In 2013, Hassan et al., synthesized a new class of DHFR inhibitors based on a 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiol skeleton and evaluated their in vitro activity against different cancer cell lines.